Show simple item record

dc.contributor.authorArrabal, Sergio
dc.contributor.authorLucena, Miguel Angel
dc.contributor.authorCanduela, Miren Josune
dc.contributor.authorRamos-Uriarte, Almudena
dc.contributor.authorRivera, Patricia
dc.contributor.authorSerrano, Antonia
dc.contributor.authorPavón, Francisco Javier
dc.contributor.authorDecara, Juan
dc.contributor.authorVargas, Antonio
dc.contributor.authorBaixeras, Elena
dc.contributor.authorMartín-Rufián, Mercedes
dc.contributor.authorMárquez, Javier
dc.contributor.authorFernández-Llébrez, Pedro
dc.contributor.authorDe Roos, Baukje
dc.contributor.authorGrandes, Pedro
dc.contributor.authorRodríguez de Fonseca, Fernando
dc.contributor.authorSuárez, Juan
dc.date.accessioned2016-01-05T16:29:03Z
dc.date.available2016-01-05T16:29:03Z
dc.date.issued2015
dc.identifier.citationArrabal , S , Lucena , M A , Canduela , M J , Ramos-Uriarte , A , Rivera , P , Serrano , A , Pavón , F J , Decara , J , Vargas , A , Baixeras , E , Martín-Rufián , M , Márquez , J , Fernández-Llébrez , P , De Roos , B , Grandes , P , Rodríguez de Fonseca , F & Suárez , J 2015 , ' Pharmacological Blockade of Cannabinoid CB1 Receptors in Diet-Induced Obesity Regulates Mitochondrial Dihydrolipoamide Dehydrogenase in Muscle ' , PloS ONE , vol. 10 , no. 12 , e0145244 . https://doi.org/10.1371/journal.pone.0145244en
dc.identifier.issn1932-6203
dc.identifier.otherPURE: 61039941
dc.identifier.otherPURE UUID: 4e6faaea-a0d3-4bdf-a590-219c4235be6b
dc.identifier.otherPubMed: 26671069
dc.identifier.otherScopus: 84970923498
dc.identifier.urihttp://hdl.handle.net/2164/5330
dc.descriptionFunding: This work was supported by CIBERobn (CB06/03/1008), Ministerio de Economía y Competitividad (MINECO) (PG: BFU2012-33334), Instituto de Salud Carlos III (ISCIII), MINECO, co-funded by UE-ERDF program (JS: CP12/03109), Red de Trastornos Adictivos (FRF: RD12/0028/0001, PG: RD12/0028/0004, JM: RD12/0028/0013), The Basque Country Government (PG: BCG IT764-13), Consejería de Economía, Innovación y Ciencia, Junta de Andalucía, UE-ERDF (FRF: CTS-8221, JM: CVI-6656), Consejería de Salud, Junta de Andalucía, UE-ERDF (FRF: SAS111224), and University of the Basque Country UPV/EHU (PG: UFI11/41). JS, FJP and AS hold “Miguel Servet” research contracts from the National System of Health, ISCIII, UE-ERDF (CP12/03109, CP14/00212, and CP14/00173 respectively)en
dc.format.extent23
dc.language.isoeng
dc.relation.ispartofPloS ONEen
dc.rightsThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0/en
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectRM Therapeutics. Pharmacologyen
dc.subject.lccRMen
dc.titlePharmacological Blockade of Cannabinoid CB1 Receptors in Diet-Induced Obesity Regulates Mitochondrial Dihydrolipoamide Dehydrogenase in Muscleen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Rowett Instituteen
dc.contributor.institutionUniversity of Aberdeen.Clinical Medicineen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1371/journal.pone.0145244


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record